Compliance and adherence to drug treatment on patients with chronic kidney disease in high prevalence areas of North Central Province, Sri Lanka

Dilan Chathuranga, Harith S. Manathunga, Sumali K. Gunasekara, Kithsiri B. Jayasekara, Ashoka Sanjeewani


Background: Chronic kidney disease that cannot be explained by traditional factors such as hypertension, diabetes mellitus is called chronic kidney disease unexplained etiology. With limited evidence on the success of interventions in enhancing medication adherence, this study was designed to test patient compliance and adherence on taking medication in North Central Province in Sri Lanka.

Methods: A cross sectional study was conducted in a selected area of NCP to identify compliance, adherence. Data was collected using an interviewer administered questionnaire by visiting patients at their own residences.

Results: A total of 200 people participated in this study. 92.5% of the population was involved in agriculture and 63% worked more than 1 acre of farmland. Among the selected population (74%) were not educated about the side effects of medication. 60.5% had missed taking their medicines during the prescribed time period. The entire population of the study was selected among patients having a monthly income of less than 15,000 Sri Lankan rupees. There was a statistically significant association in missing doses with land extent, patient’s income and stages of the disease.

Conclusions: Non adherence and compliance to the medication is common in patients that worked in largely extended lands, were in late stages of the disease and had reduced income. Compliance and Adherence to the medication can be enhanced by proper counseling and improving patient’s knowledge about their medication.


Chronic kidney disease, Compliance, Adherence towards medication treatment, Income, Stage of the disease

Full Text:



Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendrof DA, et al. medication compliance and persistence: terminology and definitions. Value Health. 2008;11:44-7.

Ho PM, Bryson CL, Rumsfeld JS. Medication adherence. Circulation. 2009;119:3028-35.

Gifford F, Kimmitt R, Herath C, Webb DJ, Siribaddana S, Melville V, et al. Arterial stiffness and Sri Lankan CKD of unknown origin. Sci Rep. 2016;6:45-9.

Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: approaches and initiatives- a position statement from kidney disease improving global outcomes. Kidney Int. 2007;72:247-59.

Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N, et al. The burden of kidney disease: improving global outcomes. Kidney Int. 2004;66:1310-4.

Weaver V, Fadrowski J. and Jaar B. Global dimensions of chronic kidney disease of unknown etiology (CKDu), a modern era environmental and/or occupational nephropathy?. BMC Nephrol. 2015;16.

Jayasekara KB, Dissanayake DM, Sivakanesan R, Ranasinghe A, Karunarathna RH, et al. Epidemiology of chronic kidney disease with special emphasis on CKD of uncertain etiology, in the north central region of Sri Lanka. J Epidemiol. 2015;25:275-80.

Chatterjee R. Occupational hazard. Science. 2016;352:24-7.

Noble A, Amarasinghe P, Manthrithilake H, Arasalingam S. Review of literature on chronic kidney disease of unknown etiology (CKDu) in Sri Lanka. J Epidemiol. 2014;24:214-8.

Abraham G, Varughese S, Thandavan T, Iyenagar A, Fernando E, Naqvi SJ, et al. Chronic kidney disease hotspots in developing countries in South Asia. Clin Kidney J. 2015;9:135-41.

Ranasinghe HRALN, Lokuge LDMN, Edirisinghe JC, Bandara L. Water treatment, preventive measures and the chronic kidney disease in farming community in Sri Lanka. J Agri Sci. 2015;10:98.

Clark PA, Chowdhury J, Chan B, Radigan N. chronic kidney disease in Nicaraguan sugarcane workers. A historical, medical, environmental analysis and ethical analysis. J Third World Med. 2016;12:16.

Razmaria AA. Chronic kidney disease. JAMA. 2016;315:2248.

Phroommintikul A, Haas SJ, Elsik M, Krum H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet. 2007;369:381-8.

Rozen ZB, Gafter GA, Paul M, Leibovici L, Shpilberg O, Gafter U. Intravenous versus oral iron supplementation for treatment of anemia CKD: Systematic review and meta-analysis. Am J Kidney Dis. 2008;52:897-901.

Chironda G, Bhengu B, Manwere A. Models and theories of care applicable to predicting and improving adherence behaviors among Chronic Kidney Disease (CKD) patients. Rwanda J Med Health Sci. 2019;2(1):48.

Rahdar Z, Jahantigh HM, Mansouri A, Siasary A, Alahyari J, Jahantigh F. Probing the relationship between treatment regimen compliance and the quality of life in hemodialysis patients: a descriptive-analytic study. Med Surg Nurs J. 2019;8:45-9.

Abeywickrama H, Wimalasiri S, Koyama Y, Uchiyama M, Shimizu U, Kakihara N, Chandrajith R. Quality of life and symptom burden among chronic kidney disease of uncertain etiology (CKDu) patients in Girandurukotte, Sri Lanka. Int J Environ Res Public Health. 2020;17:4041.

Senanayake S, Gunawardena N, Palihawadana P, Senanayake S, Karunarathna R, Kumara P, et al. Health related quality of life in chronic kidney disease. a descriptive study in a rural Sri Lankan community affected by chronic kidney disease. Health Qual Life Outcomes. 2020;18:55-9.

Premadasa M, Hulangamuwa H, Wijesooriya W, Amarasekara T. Quality of life among patients with chronic kidney disease who are undergoing hemodialysis at two selected teaching hospitals in Sri Lanka. OUSLJournal. 2019;14:31.

Tanveer S, Ashfaq M, Praveen R, Ashiq K. Assessment of the risk factors and various patient related attributes influencing hemodialysis. Int J Biosci. 2019;14:238-47.

Ranasinghe P, Perera YS, Makarim MF, wijesinghe A, wanigasuriya K. The cost in provision of hemodialysis in a developing country. a multi- centered study. BMC Nephrol. 2011;12:89-95.

Senevirathna L, Abeysekara T, Nanayakkara S, Chandrajith R, Ranathunga N, Harada KH, et al.Risk factors associated with disease progression and mortality in CKD of uncertain etiology.a cohort study in medawachchiya. Sri Lanka Environ Health Prevent Med. 2011;17:191-8.

Agarwal SK, Srivastava RK. Chronic kidney disease in India, challenges and solutions. Nephron Clin Pract. 2009;111:197-203.

Elledge MF, Redmon JH, Levine KE, Wickremasinghe RJ, Wanigasariya KP, Peiris-John RJ. Chronic kidney disease of unknown etiology in Sri Lanka: quest for understanding and global implications. RTI Press Res Brief. 2014;15:58-63.

Costantini L. Compliance, adherence and self-management:is a paradigm shift possible for chronic kidney disease clients?. CANNT J. 2005;16:22-6.

Gunathilake S, Samarathunga S, Rubasinghe R. Chronic kidney disease (CKD) in Sri Lanka-current research evidence justification: a review. Sabaragamuwa UnivJ. 2015;13:31.